Gadodiamide injection at 0.1 and 0.3 mmol/kg body weight: a phase III double-blind, parallel, randomised clinical investigation of known or suspected central nervous system lesions at 1.5 T.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples